Seroquel Long-Term NIS for Schizophrenia Patients (SELECT)

AstraZeneca

Status: Completed

Conditions: Schizophrenia; Schizoaffective Disorder

Study type: Observational

Funder types: Industry

Identifiers

NCT00523783

NIS-NKR-SER-2007/1

Details and patient eligibility

About

To assess the efficacy of 24-week treatment with quetiapine in patients with schizophrenia or schizoaffective disorder

Enrollment: 1,000 estimated patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• The patient and the patient's legal representative (if any) must understand the nature of the study and must have given written consent
• The patient suffers from schizophrenia or schizoaffective disorder according to DSM-IV-TR
• The patient is between 18 and 65 years old(extremes included)
• On the basis of physical and neurological examination, medical history, the patient is, in the investigator's opinion, otherwise healthy
• If the subject is a female of childbearing potential, she must be not pregnant or breast-feeding and be using a reliable method of contraception. Reliable methods may include abstinence, hormonal contraceptives (eg,oral contraceptives or long-term injectable or implantable hormonal contraceptives), double-barrier methods (eg, condom and diaphragm, condom and foam, condom and sponge), intrauterine devices, and tubal ligation

Exclusion criteria

• The patients who have known hypersensitivity to quetiapine